Search the Newsreel

Adaptive Biotechnologies (ADPT) Stock Looks Fair On Cash Flow Yet Rich On Sales

Adaptive Biotechnologies (ADPT) stock appears fairly valued based on its discounted cash flow model, which places its intrinsic value close to its current share price. However, the stock looks expensive when evaluated using market multiples, particularly its P/S ratio, which is significantly higher than …

OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ...

OptimizeRx Corp (OPRX) reported a 30% year-over-year revenue decrease in Q2 2026, reaching $20.5 million, with adjusted EBITDA falling to $4.1 million. Despite these revenue headwinds, the company exceeded consensus expectations, driven by strong growth in AI-enabled software and product innovations. OptimizeRx reaffirmed its …

Aptiv PLC (APTV) Stock forecasts

Argus analyst William V. Selesky views recent weakness in Aptiv PLC (APTV) stock as a long-term buying opportunity. The report notes Aptiv manufactures vehicle components and has reorganized its segments, renaming Advanced Safety and User Experience to Intelligent Systems following the spin-off of its …

OptimizeRx names Andy D’Silva as CFO, Heather Favazza as CAO

OptimizeRx Corp. (NASDAQ:OPRX) has appointed Andy D’Silva as Chief Financial Officer and Heather Favazza as Chief Accounting Officer, effective January 1, 2027. D’Silva will succeed Ed Stelmakh, who transitions to a Strategic Advisor role after serving as CFO for five years during which the …

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Susan Bobulsky Sells 3,000 Shares of Stock

Susan Bobulsky, an insider at Adaptive Biotechnologies (NASDAQ:ADPT), sold 3,000 shares of the company's stock for $75,000, reducing her total holdings by 0.75%. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Despite the sale, institutional investors own a significant 99.17% of …

Adaptive Biotechnologies CCO Susan Bobulsky sells $75,000 in shares By Investing.com

Adaptive Biotechnologies' Chief Commercial Officer, Susan Bobulsky, sold 3,000 shares of common stock totaling $75,000 at $25.00 per share on August 10, 2026. This transaction was executed under a Rule 10b5-1 trading plan and occurred while the stock was trading near its 52-week high …

How Investors May Respond To Easterly Government Properties (DEA) Upholding Dividend Amid Lower Net Income

Easterly Government Properties reported higher Q2 2026 revenue but lower net income, yet affirmed its US$0.45 quarterly dividend. This decision, despite a very large payout ratio and interest costs, highlights the company's focus on income stability for its government-leased portfolio. Investors are now evaluating …

Sarepta (SRPT) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Senior Director of Investor Relations - Tamara Thornton Chief Executive Officer - Michael E. Severino President of R&D and Technical Operations - Dr. Louise Rodino-Klapac Chief Commercial Officer …

SEPN (SEPN) plans NASDAQ sale of 746,500 shares worth $35.97M

Septerna, Inc. (SEPN) has filed a Form 144 indicating its intent to sell 746,500 common shares on NASDAQ through broker BTIG LLC, with an aggregate market value of $35,973,835.00. These shares were acquired in two blocks in May and October 2024 through IPO settlement …

Septerna, Inc. SEC Filing (Aug 12, 2026)

Septerna, Inc. has filed a Form 144 with the SEC on August 12, 2026, indicating a proposed sale of securities. The filing details the sale of 746,500 common shares acquired through an IPO on October 25, 2024, with an aggregate market value of $35,973,835.00, …

Treace Medical Concepts (TMCI) officer disposes shares for tax or exercise costs

Sean F. Scanlan, Chief Innovation Officer at Treace Medical Concepts (TMCI), reported a Form 4 transaction indicating the disposition of 9,814 shares of common stock. These shares were delivered or withheld to cover exercise price or tax liability. Following this transaction, Scanlan directly holds …

Nokia, Celestica, and Applied Optoelectronics Rally After Lumentum Sparks Broad Optics Rally

Lumentum's strong fiscal Q4 earnings report, with a 109% revenue surge and EPS beat, triggered a broad rally across the optical networking sector. Companies like Nokia, Celestica, Applied Optoelectronics, and Ciena saw significant gains as the market re-evaluated AI-driven optical demand. While the rally …

Earnings call transcript: OptimizeRx beats Q2 2026 profit view as shares slip

OptimizeRx Corp. reported Q2 2026 adjusted earnings of $0.16 per share, surpassing the $0.10 consensus, and revenue of $20.5 million, above the $20.19 million expectation. Despite beating profit views, the stock slipped after hours due to a 30% year-over-year revenue decline and continued pressure …

OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates

OptimizeRx Corp. (OPRX) exceeded Q2 earnings and revenue estimates, reporting $0.16 per share against an expected $0.11, and revenues of $20.5 million, slightly above the consensus. Despite these positive results, the company's shares have underperformed the S&P 500 this year, with a Zacks Rank …

Sean Maduck Sells 1,031 Shares of Corcept Therapeutics (NASDAQ:CORT) Stock

Sean Maduck, an insider at Corcept Therapeutics (NASDAQ:CORT), sold 1,031 shares of the company's stock on August 10th, valued at approximately $118,070, reducing his holdings by 9.56%. This sale is part of a series of transactions by Maduck in recent months. The company recently …

Treace Medical Concepts (TMCI) CFO uses 37,102 shares to cover equity-related taxes

Treace Medical Concepts (TMCI) CEO John T. Treace reports 19.2% beneficial stake

John T. Treace, CEO of Treace Medical Concepts, has filed an amended Schedule 13G indicating a 19.2% beneficial ownership stake in the company, totaling 12,530,959 shares. This ownership includes direct holdings, shares in family trusts, his spouse's holdings, and stock options exercisable within 60 …

AirSculpt Technologies (AIRS): Vesey-led group reports control of 30.3M shares

A group of investors affiliated with Vesey Street Capital, led by Adam T. Feinstein, has filed an amended Schedule 13G/A, disclosing beneficial ownership of 30,324,180 shares, or 42.1%, of AirSculpt Technologies (AIRS) common stock. This ownership includes direct holdings by various Vesey-affiliated entities and …

American Acquisition Corp. A (AEXA) logs Q2 2026 interest income and flags going concern risk

American Acquisition Corp. A (AEXA), a Cayman Islands blank check company, reported Q2 2026 net income of $2.8 million and $5.7 million for the first half, primarily from interest earned on its Trust Account investments. The company holds $355.1 million in total assets, with …

American Exceptionalism Acquisition Corp. A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Does Septerna (SEPN) Pair Narrowing Losses With A Cash Runway That Truly Supports Its Pipeline Strategy?

Septerna, Inc. reported narrowing net losses and increased sales in Q2 2026, driven by a collaboration with Novo Nordisk. The company reiterated its cash runway into 2029, supporting its early-stage clinical pipeline. Despite positive financial updates, the article notes ongoing concerns regarding Septerna's valuation …

Applied Optoelectronics (AAOI) CFO Murry sells 4,000 shares under 10b5-1 plan

Applied Optoelectronics (AAOI) CFO Stefan J. Murry sold 4,000 shares of common stock on August 10, 2026, for a total of $579,160, at a weighted average price of $144.79 per share. These transactions were conducted under a Rule 10b5-1 trading plan adopted on August …

Aptiv (APTV) director Sean O. Mahoney purchases 11,000 shares on August 11, 2026

Aptiv PLC director Sean O. Mahoney reported open-market purchases of 11,000 ordinary shares on August 11, 2026. These purchases included 4,000 shares directly at $50.287, and additional shares through two pension and savings plans. Following these transactions, Mahoney's direct holdings increased to 24,514 shares, …

OptimizeRx Refinances Debt With $35M Facility, Pays Down $8.3M

Bankrupt Sangamo scores at least $163 million in asset sale, which had two big winners

Bankrupt Sangamo Therapeutics secured at least $163 million from an asset sale, with Eli Lilly and PTC Therapeutics emerging as the primary buyers. This auction marks a crucial step in winding down Sangamo's 31-year history, a company that spent $1.7 billion on drug technologies …

OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

OptimizeRx announced its second-quarter 2026 financial results, reporting $20.5 million in revenue and a GAAP net loss of $(0.7) million. Despite a year-over-year revenue decline, the company exceeded consensus expectations for revenue and adjusted EBITDA, which stood at $4.9 million. OptimizeRx reaffirmed its fiscal …

OptimizeRx CFO Ed Stelmakh Will Advise Through End of 2027

OptimizeRx (Nasdaq: OPRX) announced a planned finance leadership transition with Andy D’Silva appointed as the new Chief Financial Officer and Heather Favazza as Chief Accounting Officer, both effective January 1, 2027. Current CFO Ed Stelmakh will continue in his role through December 31, 2026, …

OptimizeRx (OPRX) Q2 2026 revenue falls 30% but company reaffirms full-year outlook

OptimizeRx (OPRX) reported a 30% decrease in Q2 2026 revenue to $20.5 million and a GAAP net loss of $0.7 million, down from a net income of $1.5 million in Q2 2025. Despite the revenue decline and lower net revenue retention, the company reaffirmed …

Barrow Hanley Global Investors (APTV) discloses 10.8M-share Aptiv ownership stake

Barrow Hanley Global Investors has disclosed a passive beneficial ownership stake of 5.10% in Aptiv PLC, totaling 10,796,391 common shares. The firm holds sole voting power over 7,193,522 shares and shared voting power over 3,602,869 shares, with sole dispositive power over all 10,796,391 shares. …

Morgan Stanley (ATR) discloses 3.23M AptarGroup shares in Schedule 13G/A

Morgan Stanley has filed an amended Schedule 13G/A, disclosing beneficial ownership of 3,232,550 shares of AptarGroup, Inc. common stock, which represents a 5.1% stake in the company as of June 30, 2026. The filing details shared voting power over 2,870,214 shares and shared dispositive …

WORLD ACCEPTANCE CORP SEC Filing (Aug 12, 2026)

This article reports on a Form 144 SEC filing by World Acceptance Corp (WRLD) on August 12, 2026. The filing indicates a proposed sale of 2000 shares of common stock with an aggregate market value of $381,482.00, acquired through restricted stock vesting on April …

PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 4.8% - What's Next?

PROCEPT BioRobotics (NASDAQ:PRCT) shares fell 4.8% after reporting mixed Q2 2026 results with revenue growth but a larger-than-expected loss and continued unprofitability. The company faces a class-action lawsuit regarding alleged misleading statements about demand and inventory, adding to investor uncertainty. Despite a CEO stock …

Aptiv PLC stock underperforms Wednesday when compared to competitors

Aptiv PLC (APTV) shares fell 2.30% to $48.48 on Wednesday, marking its second consecutive day of losses. This underperformance occurred during a mixed trading session where the S&P 500 Index rose, but the Dow Jones Industrial Average slightly declined.

PTC Inc. stock underperforms Wednesday when compared to competitors

PTC Inc. (PTC) stock declined by 1.63% to $147.99 on Wednesday, marking its second consecutive day of losses. This underperformance occurred despite a mixed trading session where the S&P 500 Index rose 0.26% and the Dow Jones Industrial Average fell 0.04%. The article highlights …

The Bull Case For AptarGroup (ATR) Could Change Following Rising Sales, Softer EPS And Buybacks

AptarGroup (ATR) recently reported rising sales but softer net income and EPS for Q2 2026. Despite these mixed financial results, the company completed a significant share repurchase program and continues its dividend payments, indicating a consistent capital return strategy. This article suggests that while …

AirSculpt Sees Core Stabilization, Targets $100M-Plus GLP-1 Opportunity

AirSculpt Technologies (AIRS) is experiencing stabilization in its core body-contouring business after previous declines, attributing this to new talent and improved sales strategies. The company is also expanding into services for patients using GLP-1 weight-loss drugs, seeing a significant opportunity potentially exceeding $100 million …